Korro Bio is trading at $11.34 (+5.59%) with no company-specific news, moving higher alongside a broad risk-on session and strength in the biotech sector.
- The rally is supported by easing geopolitical risks and lower oil prices, providing a tailwind for growth and biotech shares.
- The broader biotech sector is showing strength, with the XBI ETF rising 2.02% as major U.S. indexes trade sharply higher.